Synexus Clinical Research US, Inc.
Vista, California, United States
Research foundation in Vista, California
161 Thunder Dr, Vista, CA 92083
About Synexus Clinical Research US, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
4
Janssen Vaccines & Prevention B.V.
1
Clinical Trials at Synexus Clinical Research US, Inc.
During the past decade, Synexus Clinical Research US, Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
2017-09-29
2020-07-08
Terminated
336
Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
2017-10-26
2020-11-09
Completed
1,650
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc."
#1 collaborator was "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Synexus Clinical Research US, Inc.
According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc." are
"Diabetes Mellitus" (2 trials), "Episodic Migraine" (2 trials), "Gastroparesis" (2 trials), "Lower Respiratory Tract Disease" (1 trials) and "Osteoarthritis, Hip" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Synexus Clinical Research US, Inc.
Most popular intervention types in "Synexus Clinical Research US, Inc." are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Atogepant" (2 trials), "Relamorelin" (2 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "Celecoxib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Clinical Research US, Inc.
The vast majority of trials in "Synexus Clinical Research US, Inc." are
6 trials for "All" genders.
Clinical Trials Status at Synexus Clinical Research US, Inc.
Currently, there are NaN active trials in "Synexus Clinical Research US, Inc.".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Synexus Clinical Research US, Inc.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".